Axsome Therapeutics Inc

Sr Director, Medical Affairs - Canada

Canada

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalsIndustries

Senior Director of Medical Affairs - Canada

Employment Type: Full-time

Company Information

PTC Therapeutics is a global commercial biopharmaceutical company dedicated to extending life’s moments for children and adults living with rare diseases. For over 25 years, our team has been driven by this unified purpose. At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.

Visit our website to learn more about our company and culture: www.ptcbio.com

Position Overview

The Senior Director of Medical Affairs is responsible for providing strategic and operational leadership for the Medical Affairs function in Canada, supporting both marketed and pipeline products. This role involves creating, building, and executing strategies aligned with global and Americas medical affairs initiatives, ensuring effective adaptation to local and regional contexts. As a member of the Americas Medical Leadership team, the Senior Director will collaborate in a diverse, fast-paced environment to deliver transformative therapies for individuals with rare diseases.

Key Responsibilities

  • Creates and implements country medical affairs strategy, influencing global and regional strategic plans.
  • Drives the tactical implementation of medical affairs plans across the country, including:
    • KOL development and relationship building.
    • Building the scientific communications platform (publications, congresses, etc.).
    • Management of other related projects.
  • Ensures execution of medical affairs strategy.
  • Manages scientific and clinical content for ongoing or new projects in close collaboration with Americas/Global medical affairs teams, the Country Manager for Canada, and heads of Marketing and Market Access.
  • Interfaces with General Managers in the Americas and North America to ensure the Canadian strategy aligns with broader goals.
  • Coaches and mentors direct reports.
  • Ensures adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs).

Role & Collaboration

  • Reports to the Vice President of Medical Affairs for the Americas.
  • Works closely with medical leaders from the US and LATAM.
  • Contributes innovative ideas and solutions to challenges faced by sub-regions.
  • Collaborates with relevant PTC functions to position the Canadian region for successful product launches and growth in the rare disease sector.

Qualifications & Skills

  • Robust scientific background with the ability to comprehend and convey complex scientific data.
  • Ability to form lasting medical and scientific partnerships with healthcare professionals.
  • Demonstrates comprehensive knowledge across multiple therapeutic areas.
  • Provides scientific and medical advice and communicates medical evidence to healthcare professionals.
  • Acts as the clinical and medical expert on PTC's products.
  • Fosters long-term relationships and builds rapport with clinicians through in-depth scientific discussions.
  • Accountable for delivering scientific publications, presentations, educational programs, and clinical data generation.
  • Responsible for the design and management of other medical affairs deliverables across Canada and the Americas region, as needed.

Application Instructions

  • [Specific application instructions would typically be listed here. As none were provided, this section remains as a placeholder.]

Location Type

  • [Location Type was not specified in the provided text.]

Salary

  • [Salary information was not specified in the provided text.]

Skills

Medical Affairs Strategy
Clinical Content Management
Regulatory Knowledge
Leadership
Cross-functional Collaboration
Global and Regional Medical Strategy
Rare Disease Expertise

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI